Form 8-K - Current report:
SEC Accession No. 0001193125-25-115489
Filing Date
2025-05-08
Accepted
2025-05-08 07:36:06
Documents
59
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d892783d8k.htm   iXBRL 8-K 26418
2 EX-99.1 d892783dex991.htm EX-99.1 100919
3 EX-99.2 d892783dex992.htm EX-99.2 45043
7 GRAPHIC g892783dsp050.jpg GRAPHIC 5527
8 GRAPHIC g892783ex99_2p10g1.jpg GRAPHIC 206166
9 GRAPHIC g892783ex99_2p11g1.jpg GRAPHIC 229430
10 GRAPHIC g892783ex99_2p12g1.jpg GRAPHIC 266385
11 GRAPHIC g892783ex99_2p13g1.jpg GRAPHIC 268966
12 GRAPHIC g892783ex99_2p14g1.jpg GRAPHIC 213619
13 GRAPHIC g892783ex99_2p15g1.jpg GRAPHIC 163663
14 GRAPHIC g892783ex99_2p16g1.jpg GRAPHIC 257484
15 GRAPHIC g892783ex99_2p17g1.jpg GRAPHIC 234484
16 GRAPHIC g892783ex99_2p18g1.jpg GRAPHIC 180476
17 GRAPHIC g892783ex99_2p19g1.jpg GRAPHIC 256652
18 GRAPHIC g892783ex99_2p1g1.jpg GRAPHIC 297533
19 GRAPHIC g892783ex99_2p20g1.jpg GRAPHIC 267818
20 GRAPHIC g892783ex99_2p21g1.jpg GRAPHIC 139952
21 GRAPHIC g892783ex99_2p22g1.jpg GRAPHIC 292036
22 GRAPHIC g892783ex99_2p23g1.jpg GRAPHIC 286949
23 GRAPHIC g892783ex99_2p24g1.jpg GRAPHIC 203866
24 GRAPHIC g892783ex99_2p25g1.jpg GRAPHIC 198127
25 GRAPHIC g892783ex99_2p26g1.jpg GRAPHIC 322412
26 GRAPHIC g892783ex99_2p27g1.jpg GRAPHIC 178355
27 GRAPHIC g892783ex99_2p28g1.jpg GRAPHIC 277365
28 GRAPHIC g892783ex99_2p29g1.jpg GRAPHIC 253583
29 GRAPHIC g892783ex99_2p2g1.jpg GRAPHIC 371532
30 GRAPHIC g892783ex99_2p30g1.jpg GRAPHIC 289454
31 GRAPHIC g892783ex99_2p31g1.jpg GRAPHIC 190830
32 GRAPHIC g892783ex99_2p32g1.jpg GRAPHIC 249610
33 GRAPHIC g892783ex99_2p33g1.jpg GRAPHIC 237348
34 GRAPHIC g892783ex99_2p34g1.jpg GRAPHIC 145728
35 GRAPHIC g892783ex99_2p35g1.jpg GRAPHIC 323195
36 GRAPHIC g892783ex99_2p36g1.jpg GRAPHIC 293440
37 GRAPHIC g892783ex99_2p37g1.jpg GRAPHIC 249394
38 GRAPHIC g892783ex99_2p38g1.jpg GRAPHIC 207189
39 GRAPHIC g892783ex99_2p39g1.jpg GRAPHIC 241224
40 GRAPHIC g892783ex99_2p3g1.jpg GRAPHIC 256720
41 GRAPHIC g892783ex99_2p40g1.jpg GRAPHIC 149382
42 GRAPHIC g892783ex99_2p41g1.jpg GRAPHIC 255971
43 GRAPHIC g892783ex99_2p42g1.jpg GRAPHIC 215114
44 GRAPHIC g892783ex99_2p43g1.jpg GRAPHIC 179673
45 GRAPHIC g892783ex99_2p4g1.jpg GRAPHIC 300198
46 GRAPHIC g892783ex99_2p5g1.jpg GRAPHIC 226341
47 GRAPHIC g892783ex99_2p6g1.jpg GRAPHIC 218926
48 GRAPHIC g892783ex99_2p7g1.jpg GRAPHIC 139806
49 GRAPHIC g892783ex99_2p8g1.jpg GRAPHIC 248414
50 GRAPHIC g892783ex99_2p9g1.jpg GRAPHIC 250791
  Complete submission text file 0001193125-25-115489.txt   14439076

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20250508.xsd EX-101.SCH 2873
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20250508_lab.xml EX-101.LAB 17925
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20250508_pre.xml EX-101.PRE 11253
61 EXTRACTED XBRL INSTANCE DOCUMENT d892783d8k_htm.xml XML 3612
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 25923921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)